Published in Medical Imaging Business Week, July 27th, 2006
"This study was designed as 'proof of concept' for a drug development model utilizing multi-tracer serial small animal PET imaging to characterize tumor responses to molecularly targeted therapy," wrote D.S. Dorow and colleagues, Peter MacCallum Cancer Center.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.